rain
Monday April 23rd, 2018 9:45AM

Johnson & Johnson tops 1Q expectations on broad sales bump

By The Associated Press
Related Articles
  Contact Editor

Health care giant Johnson & Johnson's first-quarter revenue jumped 12.6 percent as sales rose across its three business segments, but much-higher spending and one-time charges trimmed its net income by 1.2 percent. The results still beat Wall Street expectations.

The maker of baby products, medical devices and blockbuster immune disorder drug Remicade on Tuesday reported revenue of $20.01 billion, topping analyst projections for $19.48 billion, according to a poll by Zacks Investment Research.

The New Brunswick, New Jersey, company reported net income of $4.37 billion, or $1.60 per share, down from $4.42 billion, or $1.81 per share, in 2017's first quarter.

Excluding $1 billion in writedowns on the value of assets and $300 million in other one-time charges, adjusted income came to $5.54 billion, or $2.06, a nickel better than expected.

"Our pharmaceutical business continues to deliver robust growth and we are pleased with the improvement in our consumer business," Johnson & Johnson Chairman & Chief Executive Officer Alex Gorsky said in a statement.

"The U.S. tax legislation passed late last year is creating the opportunity for us to invest more than $30 billion in R&D and capital investments in the U.S. over the next four years," an increase of 15 percent, Gorsky added.

In the first quarter, J&J increased spending on research and development by 16 percent, while spending on production jumped 22 percent and spending on marketing and administration rose nearly 11 percent.

Marketing and production costs were higher partly because of the launch of its new severe psoriasis drug, Tremfya, approved last summer. The company also had another medicine, Erleada for prostate cancer, approved on Feb. 14.

The world's biggest maker of health care products reported that overseas sales jumped 20 percent, buoyed by favorable currency exchange rates.

"They did just okay on an operating basis when you strip out growth bought via acquisitions," said Erik Gordon, a professor and pharmaceuticals analyst at University of Michigan's Ross School of Business, adding, "The good news is that some of their newer products with patent life left in them are selling well."

Johnson & Johnson forecast full-year earnings in the range of $8 to $8.20 per share, with revenue in the range of $81 billion to $81.8 billion.

In premarket trading, shares rose $1.16, or 0.9 percent, to $133.

_____

Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.

_____

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2018 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
China's economic growth holds steady amid trade dispute
China economy expands at 6.8 percent pace in Jan-March, buoyed by retail sales and investment
7:52AM ( 15 minutes ago )
The Latest: Danish PM backs call to consult EU citizens more
Denmark's Prime Minister Lars Loekke Rasmussen has welcomed the speech by French President Emmanuel Macron to the European Parliament, saying it was "good to hear" him "calling for consulting citizens on EU's future."
7:51AM ( 16 minutes ago )
Global stocks turn higher on upbeat corporate earnings
Global shares are mixed amid persisting worries over trade tensions between China and the U.S.
7:49AM ( 19 minutes ago )
Associated Press (AP)
Johnson & Johnson tops profit and revenue expectations in 1Q
Johnson & Johnson is reporting better than expected profit and revenue for the first quarter
7:04AM ( 1 hour ago )
Japan's Abe to meet with Trump as scandals swirl at home
Domestic political scandals and a sinking support rating are weighing on Japanese Prime Minister Shinzo Abe as he heads to talks with U.S. President Donald Trump
7:03AM ( 1 hour ago )
Top EU court: Poland broke law by logging in pristine forest
The European Union's top court has ruled that Poland violated environmental laws with its massive logging of trees in one of Europe's last pristine forests
6:57AM ( 1 hour ago )
AP Business
The Latest: Mayor says Starbucks 'contrite' over arrests
Philadelphia officials have wrapped up a meeting with Starbucks executives to discuss the arrests of two black men who were denied use of a store's bathroom and refused to leave
9:26PM ( 10 hours ago )
Starbucks to train workers on 'unconscious bias,' CEO says
Starbucks CEO says company will train workers on 'unconscious bias'
9:25PM ( 10 hours ago )
Lawsuit dropped between Elaine Wynn and ex's former company
A years-long boardroom battle involving the company founded by embattled former Las Vegas casino mogul Steve Wynn and his ex-wife has settled on the brink of the start of trial in Nevada state court
8:15PM ( 11 hours ago )
AP Business - Corporate News
Trump puts forward 2 more nominees for Fed board
Trump puts forward 2 more nominees for Fed board including Columbia professor as vice chairman
3:53PM ( 16 hours ago )
Tech, industrial stocks are big gainers as US indexes rally
U.S. stocks are broadly higher in afternoon trading, adding to the market's gains last week
2:26PM ( 17 hours ago )
Tech companies, banks are big gainers as US stocks rally
U.S. stocks are broadly higher in morning trading, adding to the market's gains last week
11:25AM ( 20 hours ago )
AP Business - Industries
Defiant Syrians say West hasn't shaken their resolve
Hundreds of Syrians filled the streets of Damascus in defiance of what they called the West's "failure" to shake their nation's resolve with airstrikes that jolted the capital only hours earlier
7:36PM ( 2 days ago )
Technology, industrials and banks lead rally as stocks rise
Banks and technology and industrial companies help US stocks add to their gains from earlier in the week
4:52PM ( 4 days ago )
Stocks jump as technology, industrials and banks rally
US stocks are adding to their big gains earlier this week as banks and technology and industrial companies climb
12:57PM ( 4 days ago )
AP Business - Health Care
China's economic growth holds steady amid trade dispute
China economy expands at 6.8 percent pace in Jan-March, buoyed by retail sales and investment
7:52AM ( 15 minutes ago )
The Latest: Danish PM backs call to consult EU citizens more
Denmark's Prime Minister Lars Loekke Rasmussen has welcomed the speech by French President Emmanuel Macron to the European Parliament, saying it was "good to hear" him "calling for consulting citizens on EU's future."
7:51AM ( 16 minutes ago )
Global stocks turn higher on upbeat corporate earnings
Global shares are mixed amid persisting worries over trade tensions between China and the U.S.
7:49AM ( 19 minutes ago )
Destruction, traumatized residents in Syrian town of Douma
In Syrian town of Douma near Damascus, destruction and traumatized residents
7:41AM ( 26 minutes ago )
Starbucks faces image crisis after arrest of 2 black men
Through the looking glass: Arrest of black men is a blow to the inclusive image Starbucks has cultivated
7:36AM ( 32 minutes ago )